Ameritas Investment Partners’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-954
| Closed | -$4.66K | – | 3216 |
|
|
2025
Q1 | $4.66K | Hold |
954
| – | – | ﹤0.01% | 2989 |
|
|
2024
Q4 | $7.96K | Sell |
954
-1
| -0.1% | -$9 | ﹤0.01% | 2957 |
|
|
2024
Q3 | $9.92K | Hold |
955
| – | – | ﹤0.01% | 2921 |
|
|
2024
Q2 | $18.8K | Hold |
955
| – | – | ﹤0.01% | 2643 |
|
|
2024
Q1 | $24.4K | Buy |
955
+520
| +120% | +$13.3K | ﹤0.01% | 2483 |
|
|
2023
Q4 | $12K | Hold |
435
| – | – | ﹤0.01% | 2785 |
|
|
2023
Q3 | $26.4K | Buy |
435
+103
| +31% | +$7.24K | ﹤0.01% | 2417 |
|
|
2023
Q2 | $21.9K | Hold |
332
| – | – | ﹤0.01% | 2519 |
|
|
2023
Q1 | $21.1K | Hold |
332
| – | – | ﹤0.01% | 2442 |
|
|
2022
Q4 | $41.1K | Buy |
332
+67
| +25% | +$9.44K | ﹤0.01% | 2198 |
|
|
2022
Q3 | $33K | Hold |
265
| – | – | ﹤0.01% | 2255 |
|
|
2022
Q2 | $21K | Hold |
265
| – | – | ﹤0.01% | 2521 |
|
|
2022
Q1 | $26K | Hold |
265
| – | – | ﹤0.01% | 2435 |
|
|
2021
Q4 | $53K | Sell |
265
-144
| -35% | -$34K | ﹤0.01% | 2090 |
|
|
2021
Q3 | $101K | Hold |
409
| – | – | ﹤0.01% | 1680 |
|
|
2021
Q2 | $169K | Buy |
+409
| New | +$162K | 0.01% | 1371 |
|
|
2018
Q2 | – | Sell |
-320
| Closed | -$708K | – | 3007 |
|
|
2018
Q1 | $708K | Hold |
320
| – | – | 0.03% | 645 |
|
|
2017
Q4 | $739K | Buy |
320
+23
| +8% | +$46.7K | 0.03% | 647 |
|
|
2017
Q3 | $480K | Buy |
297
+19
| +7% | +$26.5K | 0.02% | 763 |
|
|
2017
Q2 | $378K | Buy |
278
+15
| +6% | +$18.1K | 0.02% | 813 |
|
|
2017
Q1 | $310K | Hold |
263
| – | – | 0.02% | 871 |
|
|
2016
Q4 | $210K | Buy |
263
+16
| +6% | +$12.7K | 0.01% | 1013 |
|
|
2016
Q3 | $217K | Buy |
+247
| New | +$179K | 0.01% | 976 |
|
|
2015
Q2 | – | Sell |
-168
| Closed | -$263K | – | 1172 |
|
|
2015
Q1 | $263K | Buy |
+168
| New | +$222K | 0.02% | 894 |
|
Other funds holding BLUE
Ameritas Investment Partners's BLUE Position: Q2 2025 in Review
Ameritas Investment Partners sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 954 shares — an estimated $4.66K sold.
Ameritas Investment Partners first reported a position in BLUE in Q1 2015 and held it in 24 quarters. The position peaked at $739K in Q4 2017. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- Ameritas Investment Partners reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- Ameritas Investment Partners sold 954 bluebird bio shares in Q2 2025, an estimated $4.66K.
- Ameritas Investment Partners first reported a position in bluebird bio in Q1 2015 and held it in 24 quarters.
- Ameritas Investment Partners's bluebird bio position peaked at $739K in Q4 2017.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.